HMC
Harvard Management Company’s Seres Therapeutics MCRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-131,847
| Closed | -$314K | – | 16 |
|
|
2023
Q3 | $314K | Hold |
131,847
| – | – | 0.04% | 22 |
|
|
2023
Q2 | $632K | Hold |
131,847
| – | – | 0.06% | 30 |
|
|
2023
Q1 | $748K | Hold |
131,847
| – | – | 0.08% | 42 |
|
|
2022
Q4 | $738K | Hold |
131,847
| – | – | 0.09% | 41 |
|
|
2022
Q3 | $846K | Hold |
131,847
| – | – | 0.11% | 44 |
|
|
2022
Q2 | $452K | Hold |
131,847
| – | – | 0.05% | 43 |
|
|
2022
Q1 | $939K | Hold |
131,847
| – | – | 0.09% | 43 |
|
|
2021
Q4 | $1.1M | Hold |
131,847
| – | – | 0.1% | 43 |
|
|
2021
Q3 | $918K | Hold |
131,847
| – | – | 0.05% | 38 |
|
|
2021
Q2 | $3.15M | Hold |
131,847
| – | – | 0.18% | 33 |
|
|
2021
Q1 | $2.72M | Hold |
131,847
| – | – | 0.15% | 36 |
|
|
2020
Q4 | $3.23M | Buy |
+131,847
| New | +$3.23M | 0.18% | 24 |
|